Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$3.39bnn/an/a
au flag iconMSBMesoblastAU$2.87bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.40bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.16bnn/an/a
au flag iconIMMImmutepAU$567.38mn/an/a
au flag iconRACRacura OncologyAU$429.15mn/an/a
au flag iconCGSCogstateAU$392.86m26.440.81%
au flag iconDXBDimerixAU$284.29mn/an/a
au flag iconTTXTetratherixAU$194.78mn/an/a
au flag iconNYRNyradaAU$161.77mn/an/a
au flag iconACWActinogen MedicalAU$130.26mn/an/a
au flag iconBXNBioxyneAU$129.89m26.32n/a
au flag iconPARParadigm BiopharmaceuticalsAU$101.25mn/an/a
au flag iconALAArovella TherapeuticsAU$98.50mn/an/a
au flag iconILAIsland PharmaceuticalsAU$87.35mn/an/a
au flag iconCYPCynata TherapeuticsAU$82.47mn/an/a
au flag iconLTPLtr PharmaAU$81.44mn/an/a
au flag iconATHAlterity TherapeuticsAU$73.02mn/an/a
au flag iconRHYRhythm BiosciencesAU$72.46mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a